Literature DB >> 12557046

In utero models of craniofacial surgery.

Tamara R Harling1, Eric J Stelnicki, Marc H Hedrick, Michael T Longaker.   

Abstract

Fetal surgery is finding ever-increasing applications. At present, fetal surgical techniques are used only to treat diseases associated with high mortality risk or severe morbidity if left untreated prior to birth. Yet as a discipline, in utero therapy is attractive to plastic surgeons because it affords the potential to (1) provide a scarless repair, (2) correct the primary deformity, (3) prevent secondary deformities, and (4) give the parents a "normal"-appearing child at birth. Each of these potential benefits is particularly important in patients with craniofacial anomalies. This article will both review the animal models that have been used to study the potential for intrauterine plastic surgery and provide a synopsis of the benefits that fetal therapy may provide in the treatment of selected craniofacial anomalies.

Entities:  

Mesh:

Year:  2003        PMID: 12557046     DOI: 10.1007/s00268-002-6745-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  3 in total

1.  Toward Microsurgical Correction of Cleft Lip Ex Utero through Restoration of Craniofacial Developmental Programs.

Authors:  Xue Dong; Wilmina N Landford; James Hart; Maurizio Risolino; Omer Kaymakcalan; Julia Jin; Yoshiko Toyoda; Elisabetta Ferretti; Licia Selleri; Jason A Spector
Journal:  Plast Reconstr Surg       Date:  2017-07       Impact factor: 4.730

2.  A rabbit model for experimental alveolar cleft grafting.

Authors:  Mohammad Kamal; Lars Andersson; Rene Tolba; Alexander Bartella; Felix Gremse; Frank Hölzle; Peter Kessler; Bernd Lethaus
Journal:  J Transl Med       Date:  2017-02-24       Impact factor: 5.531

3.  Identification of differentially expressed proteins involved in fetal scarless wound healing using a rat model of cleft lip.

Authors:  Yu Yan; Hong Liu; Jiarong Yi; Zizi Chen; Jia Chen; Jianfei Zhang; Kewa Gao; Siqi He; Aijun Wang; Ping Jin; Feng Hu; Jianda Zhou
Journal:  Mol Med Rep       Date:  2021-06-24       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.